Invesco China Health Care Equity Fd.C H
LU2243645046
Invesco China Health Care Equity Fd.C H/ LU2243645046 /
NAV30.05.2024 |
Zm.-0,0100 |
Typ dystrybucji dochodów |
Kategoria |
Firma inwestycyjna |
4,6700SGD |
-0,21% |
z reinwestycją |
Akcje
Sector Health / Pharma
|
Invesco Management ▶ |
Strategia inwestycyjna
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
Cel inwestycyjny
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
Dane podstawowe
Typ dystrybucji dochodów: |
z reinwestycją |
Kategoria funduszy: |
Akcje |
Kraj: |
Chiny |
Branża: |
Sector Health / Pharma |
Benchmark: |
MSCI China A Onshore Health Care Index |
Początek roku obrachunkowego: |
29.02 |
Last Distribution: |
- |
Bank depozytariusz: |
- |
Kraj pochodzenia funduszu: |
Luxemburg |
Zezwolenie na dystrybucję: |
Austria, Niemcy, Szwajcaria |
Zarządzający funduszem: |
Chris Liu, Kehong Jiang |
Aktywa: |
486,11 mln
EUR
|
Data startu: |
15.12.2020 |
Koncentracja inwestycyjna: |
- |
Warunki
Opłata za nabycie: |
5,00% |
Max. Administration Fee: |
1,00% |
Minimalna inwestycja: |
1 200 000,00 SGD |
Opłaty depozytowe: |
0,01% |
Opłata za odkupienie: |
0,00% |
Uproszczony prospekt: |
Ściągnij (Wersja do wydruku) |
Firma inwestycyjna
TFI: |
Invesco Management |
Adres: |
An der Welle 5, 60322, Frankfurt am Main |
Kraj: |
Niemcy |
Internet: |
www.de.invesco.com
|
Aktywa
Akcje |
|
96,91% |
Gotówka |
|
3,09% |
Kraje
Chiny |
|
65,14% |
Gotówka |
|
3,09% |
Kajmany |
|
3,05% |
Inne |
|
28,72% |
Branże
Farmacja/biotechnologia |
|
50,29% |
Medyczne produkty i instrumenty |
|
14,53% |
Usługi zdrowotne |
|
3,36% |
Pieniądze |
|
3,09% |
Inne |
|
28,73% |